Fina Biosolutions LLC
Fina Biosolutions LLC, founded in 2006 by Dr. Andrew Lees, specializes in providing bioconjugation services and products to facilitate the manufacture of affordable conjugate vaccines, particularly for emerging market manufacturers. Headquartered in Rockville, Maryland, within the biotechnology corridor, the company leverages its expertise in conjugation chemistry and functionalized dextran production to support the biotech and vaccine industries.
With a focus on carrier proteins like CRM197 and rTTHc, Fina Biosolutions offers a range of tailored services, including protein services and analytical assessments. Their commitment to advancing vaccine technology is evident in their provision of resources such as white papers and specialized training programs to help clients enhance their capabilities in vaccine development.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.